The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells

BACKGROUND: Liver cancer is one of the most frequent cancers in the world. Targeted therapy of cancer with specific inhibitors is developing and has shown promising antitumor efficacy. CCI-779 (temsirolimus), a specific inhibitor of mTOR (mammalian target of rapamycin), can block the mTOR signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuyu, Liang, Yan, Wu, Manlin, Wang, Xiaojing, Fu, Haixia, Chen, Yuhao, Wang, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632488/
https://www.ncbi.nlm.nih.gov/pubmed/23537100
http://dx.doi.org/10.1186/1475-2867-13-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632488/
https://www.ncbi.nlm.nih.gov/pubmed/23537100
http://dx.doi.org/10.1186/1475-2867-13-30

Ejemplares similares